Study of XL820 in Adults With Solid Tumors
NCT00129571 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2008-06-04
Summary
The purpose of this study is to assess the safety and tolerability of XL820 when given orally to adults with advanced solid tumors.
Conditions
Interventions
- DRUG
-
XL820
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
Countries
- United States
Study Locations
More Related Trials
-
CHS 828 in Treating Patients With Solid Tumors
NCT00003979 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors
NCT00796484 ·Status: TERMINATED ·Phase: PHASE1
-
XK469 in Treating Patients With Advanced Solid Tumors
NCT00028548 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
NCT07123103 ·Status: RECRUITING ·Phase: PHASE1
-
Study of XL999 in Adults With Solid Tumors
NCT00104117 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
NCT00820560 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of XS-02 Capsules in Patients With Advanced Solid Tumors
NCT06531486 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects
NCT01359982 ·Status: COMPLETED ·Phase: PHASE1
-
Subjects With Advanced or Metastatic Solid Tumor Malignancies
NCT05474859 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
NCT00869388 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL418 in Adults With Solid Tumors
NCT00460278 ·Status: SUSPENDED ·Phase: PHASE1
-
BIBX 1382 in Treating Patients With Solid Tumors
NCT00003980 ·Status: SUSPENDED ·Phase: PHASE1
-
Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer
NCT01449370 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors
NCT06630247 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
NCT02952248 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors
NCT00880308 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
NCT01413906 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors
NCT03934359 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL281 in Adults With Solid Tumors
NCT00451880 ·Status: COMPLETED ·Phase: PHASE1
-
Study of PKI-179 Administered Orally to Subjects With Solid Tumors
NCT00997360 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer
NCT00773929 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AS1411 in Advanced Solid Tumours
NCT00881244 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of KX2-391 in Patients With Advanced Malignancies
NCT00658970 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of LCL161 in Patients With Solid Tumors
NCT01098838 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
NCT01068483 ·Status: COMPLETED ·Phase: PHASE1